EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual targeting of SLC6A14 and autophagy/macropinocytosis enhances therapeutic efficacy in pancreatic ductal adenocarcinoma

Mosharaf Mahmud Syed, Devaraja Rajasekaran, Souad R Sennoune, Tanima Sharker, Oscar Sanchez, Mary Katherine Jurek, Longfa Kou, Ruijie Chen, Vadivel Ganapathy, Yangzom D Bhutia iD

Biochemical Journal · 05.08.2026 · 483 (8) · 1369-1390

DOI: 10.1042/bcj20250155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Journal, online erschienen am 02.07.2026. Verfasst von Mosharaf Mahmud Syed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Autophagy, Pinocytosis, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Cancer Institute (NCI), Cancer Prevention and Research Institute of Texas (CPRIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is highly desmoplastic and undergoes metabolic reprogramming to sustain its growth and proliferation. Our laboratory has identified SLC6A14, an amino acid transporter, as a novel drug target for PDAC. Genetic deletion of SLC6A14 or its pharmacological blockade with α-MLT attenuates PDAC growth by inducing amino acid deprivation. However, nutrient stress, particularly amino acid deprivation, can induce nutrient scavenging mechanisms like autophagy and macropinocytosis, thereby undermining the full anticancer potential of SLC6A14 blockade. To address this, the current work was conducted to test whether SLC6A14 blockade induces autophagy and/or macropinocytosis and to further investigate whether dual inhibition of SLC6A14 (α-MLT) and autophagy/macropinocytosis (HCQ) would yield a better therapeutic outcome in PDAC as opposed to targeting SLC6A14 alone. In vitro assays (MTT and colony formation) revealed that the combination treatment significantly reduced PDAC cell viability and clonogenic potential as opposed to monotherapy. The treatment model subcutaneous xenograft in athymic nude mice demonstrated a superior therapeutic outcome with the combination regimen. Collectively, our study demonstrates that the afore-described combination therapy creates a metabolic trap wherein α-MLT induces nutrient stress, while HCQ prevents autophagic and macropinocytosis compensation, thus culminating in a more potent tumor attenuation. This dual blockade represents a hitherto unexplored treatment strategy for PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalAutophagyPinocytosisPancreatic NeoplasmsAmino Acid Transport SystemsHumansAnimalsCell Line, TumorMiceMice, NudeFemale

Stichwörter der Autor:innen

Alpha-methyl-l-tryptophanMacropinocytosisPancreatic ductal adenocarcinomaSLC6A14autophagyhydroxychloroqine

Substanzen

SLC6A14 protein, humanAmino Acid Transport Systems

Autor:innen und Institutionen

  • Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, U.S.A.
  • Department of Psychiatry, Tufts Medical Center, 800 Washington St., Boston, MA 02111, U.S.A.
  • Department of Pharmacy, Wenzhou Municipal Key Laboratory of Pediatric Pharmacy, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China.

ORCID-Profile: Yangzom D Bhutia

Förderung

  • HHS | NIH | National Cancer Institute (NCI)
  • Cancer Prevention and Research Institute of Texas (CPRIT)

Zitieren

APA

Mahmud Syed, M., Rajasekaran, D., Sennoune, S. R., Sharker, T., Sanchez, O., Jurek, M. K., Kou, L., Chen, R., Ganapathy, V., & Bhutia, Y. D. (2026). Dual targeting of SLC6A14 and autophagy/macropinocytosis enhances therapeutic efficacy in pancreatic ductal adenocarcinoma. Biochemical Journal, 483(8), 1369-1390. https://doi.org/10.1042/bcj20250155

Vancouver

Mahmud Syed M, Rajasekaran D, Sennoune SR, Sharker T, Sanchez O, Jurek MK, et al. Dual targeting of SLC6A14 and autophagy/macropinocytosis enhances therapeutic efficacy in pancreatic ductal adenocarcinoma. Biochemical Journal. 2026;483(8):1369-1390. doi:10.1042/bcj20250155

BibTeX
@article{MahmudSyed2026,
  author = {Mahmud Syed, Mosharaf and Rajasekaran, Devaraja and Sennoune, Souad R and Sharker, Tanima and Sanchez, Oscar and Jurek, Mary Katherine and Kou, Longfa and Chen, Ruijie and Ganapathy, Vadivel and Bhutia, Yangzom D},
  title = {Dual targeting of SLC6A14 and autophagy/macropinocytosis enhances therapeutic efficacy in pancreatic ductal adenocarcinoma},
  journal = {Biochemical Journal},
  year = {2026},
  volume = {483},
  number = {8},
  pages = {1369--1390},
  doi = {10.1042/bcj20250155}
}
Kostenlos starten →